---
figid: PMC4845654__nihms777596f4
figtitle: 'Beyond Beta-catenin: prospects for a larger catenin network in the nucleus'
organisms:
- Xenopus laevis
- Dipnomorpha
- Homo sapiens
- Mus musculus
- Caenorhabditis elegans
- Lareunionomyces loeiensis
organisms_ner:
- Homo sapiens
- Mus musculus
- Xenopus laevis
pmcid: PMC4845654
filename: nihms777596f4.jpg
figlink: /pmc/articles/PMC4845654/figure/F4/
number: F4
caption: a | Analogous to the case for β-catenin, p120 catenin isoform 1 is stabilized
  in response to WNT signalling. This enables the signalling pool of p120 catenin
  isoform 1 to increase and relieve Kaiso-mediated repression, thereby activating
  transcription. Alternative, shorter p120 catenin isoforms (that is, isoforms 2–4;
  see ) may also relieve Kaiso-mediated repression, but they are not as sensitive
  to canonical WNT regulation. A number of genes seem to be co-regulated by β-catenin–T
  cell factor (TCF) and p120 catenin–Kaiso. An alternative model of p120 catenin function
  in regulating Kaiso and TCF-mediated gene expression is referenced in the text.
  b | p120 catenin can be released into the cytoplasm by E-cadherin loss or E-cadherin
  downregulation, or via changes in cadherin or p120 catenin phosphorylation states.
  Nuclear p120 displaces the RE1-silencing transcription factor (REST)–CoREST repressive
  complex from REST target genes to activate transcription (pathway labelled 1 in
  the scheme). Additionally, GLIS2 enhances nuclear entry of p120 catenin, which in
  turn enhances the cleavage of GLIS2 within its DNA-binding zinc-finger domain by
  an unknown mechanism. This may reduce GLIS2 repressor function, resulting in gene
  activation mediated by GLIS2 (pathway labelled 2 in the scheme). APC, adenomatous
  polyposis coli; CK1α, casein kinase 1α; GSK3β, glycogen synthase kinase 3β; LEF,
  lymphoid enhancer-binding factor; LRP, low-density lipoprotein receptor-related
  protein.
papertitle: 'Beyond β-catenin: prospects for a larger catenin network in the nucleus.'
reftext: Pierre D. McCrea, et al. Nat Rev Mol Cell Biol. ;17(1):55-64.
year: ''
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9793373
figid_alias: PMC4845654__F4
figtype: Figure
redirect_from: /figures/PMC4845654__F4
ndex: abf3e648-debb-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4845654__nihms777596f4.html
  '@type': Dataset
  description: a | Analogous to the case for β-catenin, p120 catenin isoform 1 is
    stabilized in response to WNT signalling. This enables the signalling pool of
    p120 catenin isoform 1 to increase and relieve Kaiso-mediated repression, thereby
    activating transcription. Alternative, shorter p120 catenin isoforms (that is,
    isoforms 2–4; see ) may also relieve Kaiso-mediated repression, but they are not
    as sensitive to canonical WNT regulation. A number of genes seem to be co-regulated
    by β-catenin–T cell factor (TCF) and p120 catenin–Kaiso. An alternative model
    of p120 catenin function in regulating Kaiso and TCF-mediated gene expression
    is referenced in the text. b | p120 catenin can be released into the cytoplasm
    by E-cadherin loss or E-cadherin downregulation, or via changes in cadherin or
    p120 catenin phosphorylation states. Nuclear p120 displaces the RE1-silencing
    transcription factor (REST)–CoREST repressive complex from REST target genes to
    activate transcription (pathway labelled 1 in the scheme). Additionally, GLIS2
    enhances nuclear entry of p120 catenin, which in turn enhances the cleavage of
    GLIS2 within its DNA-binding zinc-finger domain by an unknown mechanism. This
    may reduce GLIS2 repressor function, resulting in gene activation mediated by
    GLIS2 (pathway labelled 2 in the scheme). APC, adenomatous polyposis coli; CK1α,
    casein kinase 1α; GSK3β, glycogen synthase kinase 3β; LEF, lymphoid enhancer-binding
    factor; LRP, low-density lipoprotein receptor-related protein.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - LRP5
  - FZD1
  - FZD10
  - FZD2
  - FZD3
  - FZD4
  - FZD5
  - FZD6
  - FZD7
  - FZD8
  - FZD9
  - WNT1
  - WNT2
  - WNT2B
  - WNT3
  - WNT3A
  - WNT4
  - WNT6
  - WNT7A
  - WNT7B
  - WNT8A
  - WNT8B
  - WNT9A
  - WNT9B
  - WNT10A
  - WNT10B
  - WNT11
  - WNT16
  - WNT5A
  - WNT5B
  - LRP6
  - CDH1
  - CDH10
  - CDH11
  - CDH12
  - CDH13
  - CDH15
  - CDH16
  - CDH17
  - CDH18
  - CDH19
  - CDH2
  - CDH20
  - CDH22
  - CDH24
  - CDH3
  - CDH4
  - CDH5
  - CDH6
  - CDH7
  - CDH8
  - CDH9
  - CTNND1
  - IGSF1
  - NOP2
  - RASA1
  - TRPA1
  - BRD8
  - NSUN5
  - CTNNB1
  - KRT10
  - AXIN1
  - AXIN2
  - APC
  - PROC
  - GSK3B
  - SEMA6A
  - GLIS2
  - RCOR1
  - REST
  - HNF4A
  - Lrp5
  - Lrp6
  - Ctnnd1
  - Ctnnb1
  - Axin1
  - Apc
  - Gsk3b
  - Sema6a
  - Glis2
  - Rcor2
  - Rest
  - Zbtb33
  - lrp5.L
  - lrp6.L
  - lrp6.S
  - arvcf.L
  - ctnnd1.L
  - ctnnb1.S
  - ctnnb1.L
  - axin1.S
  - apc.L
  - gsk3b.L
  - gsk3b.S
  - glis2.L
  - glis2.S
  - rcor1.L
  - rest.S
  - zbtb33.S
  - zbtb33.L
---
